Josep M. Gatell
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial.
Journal: HIV medicine
Published: September 03, 2020
The EuroSIDA study: 25 years of scientific achievements.
Journal: HIV medicine
Published: June 11, 2019
Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997-2015): a prospective cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: July 17, 2018
Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717.
Journal: The Journal of antimicrobial chemotherapy
Published: April 07, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
Journal: HIV medicine
Published: March 06, 2018
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
Journal: HIV medicine
Published: May 06, 2017
Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity.
Journal: Human vaccines & immunotherapeutics
Published: April 21, 2017
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis.
Journal: The Journal of antimicrobial chemotherapy
Published: April 01, 2017
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
Journal: The Journal of antimicrobial chemotherapy
Published: June 17, 2016
Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy.
Journal: HIV clinical trials
Published: April 30, 2016
Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection.
Journal: Journal of virology
Published: January 07, 2016
Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.
Journal: Biochimica et biophysica acta
Published: November 20, 2015
Last Updated: 09/26/2026